DK0925064T3 - 5-Androsten-3-beta,17-alpha-diol som inhibitor for tumorvækst - Google Patents

5-Androsten-3-beta,17-alpha-diol som inhibitor for tumorvækst

Info

Publication number
DK0925064T3
DK0925064T3 DK97920244T DK97920244T DK0925064T3 DK 0925064 T3 DK0925064 T3 DK 0925064T3 DK 97920244 T DK97920244 T DK 97920244T DK 97920244 T DK97920244 T DK 97920244T DK 0925064 T3 DK0925064 T3 DK 0925064T3
Authority
DK
Denmark
Prior art keywords
alpha
beta
androsten
diol
inhibitor
Prior art date
Application number
DK97920244T
Other languages
English (en)
Inventor
Roger M Loria
Original Assignee
Roger M Loria
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roger M Loria filed Critical Roger M Loria
Application granted granted Critical
Publication of DK0925064T3 publication Critical patent/DK0925064T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DK97920244T 1996-04-11 1997-04-10 5-Androsten-3-beta,17-alpha-diol som inhibitor for tumorvækst DK0925064T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1504296P 1996-04-11 1996-04-11
US1898596P 1996-06-04 1996-06-04
PCT/US1997/005849 WO1997037662A1 (en) 1996-04-11 1997-04-10 5-ANDROSTENE 3β,17α DIOL AS AN INHIBITOR OF TUMOR GROWTH

Publications (1)

Publication Number Publication Date
DK0925064T3 true DK0925064T3 (da) 2003-10-20

Family

ID=26686886

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97920244T DK0925064T3 (da) 1996-04-11 1997-04-10 5-Androsten-3-beta,17-alpha-diol som inhibitor for tumorvækst

Country Status (8)

Country Link
EP (1) EP0925064B1 (da)
JP (1) JP2000508643A (da)
AT (2) ATE311886T1 (da)
DE (2) DE69723087T2 (da)
DK (1) DK0925064T3 (da)
ES (2) ES2254828T3 (da)
PT (1) PT925064E (da)
WO (1) WO1997037662A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1362591T3 (da) * 1996-04-11 2006-04-10 Roger M Loria Anvendelse af en sammensætning indeholdende 5-androsten-3beta, 17alfa-diol
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
CA2386095A1 (en) * 1999-09-30 2001-04-05 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
US7241753B2 (en) 2000-02-25 2007-07-10 Loria Roger M Method of treatment of prostate cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US5461042A (en) * 1988-12-30 1995-10-24 Loria; Roger M. Regulation of the immune system
US5206008A (en) * 1991-04-15 1993-04-27 Virginia Commonwealth University Enhancement of immune response
US5478566A (en) * 1993-09-29 1995-12-26 Loria; Roger M. Stimulation of cytokine production

Also Published As

Publication number Publication date
EP0925064A1 (en) 1999-06-30
EP0925064B1 (en) 2003-06-25
ATE243518T1 (de) 2003-07-15
DE69723087D1 (de) 2003-07-31
WO1997037662A1 (en) 1997-10-16
PT925064E (pt) 2003-11-28
DE60308917T2 (de) 2006-12-28
EP0925064A4 (en) 2001-11-07
ES2202606T3 (es) 2004-04-01
ATE311886T1 (de) 2005-12-15
DE60308917D1 (de) 2006-11-16
JP2000508643A (ja) 2000-07-11
DE69723087T2 (de) 2004-05-06
ES2254828T3 (es) 2006-06-16

Similar Documents

Publication Publication Date Title
GR3036188T3 (en) Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
AU2332188A (en) Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors
DE69729786D1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
TR200100366T2 (tr) Aktif madde dağıtmaya mahsus bileşikler ve bileşimler.
ES2195664T3 (es) Uso de fumaratos de dialquilo.
NO20001583D0 (no) Stimulering av hematopoetiske celler in vitro
DE3161494D1 (en) Cosmetic preparations
AU644610B2 (en) Synergistic microbicidal combinations
HK1142093A1 (en) Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
IL128205A0 (en) Potassium channel inhibitors and pharmaceutical compositions containing the same
MY100641A (en) Neutral metalloendopeptidase inhibitors in the treatment of hypertension.
GB2184354B (en) Stabilized human tissue plasminogen activator compositions
ZA933598B (en) New pharmaceutical used of krill enyzmes
FR2751879B1 (fr) Composition pharmaceutique contre les tumeurs et infections a papillomavirus
FR2662698B1 (da)
AU8332791A (en) Oral pharmaceutical compositions containing melatonin
DK0925064T3 (da) 5-Androsten-3-beta,17-alpha-diol som inhibitor for tumorvækst
AU4751797A (en) Defined systems for epithelial cell culture and use thereof
GB2324091A (en) Metalloproteinase inhibitors
CA2252110A1 (en) 5-androstene 3.beta.,17.alpha. diol as an inhibitor of tumor growth
MX9705959A (es) Formulaciones para il-12.
MX9703208A (es) Tetra-y pentapeptidos substituidos inhibidores de proteina; farnesil transferasa.
IT1267004B1 (it) Proteine estratte dai semi di saponaria ocymoides e di vaccaria pyramidata, loro preparazione ed uso come antitumorale ed antivirale.
MX9800697A (es) Uso de glicosidos de calendula para el tratamiento de psoriasis.